2025
|
G/S
|
Pharmaceutical preparations for the treatment of tumor; pharmaceutical preparations for the treat... |
|
Invention
|
Sulfonamide compounds and use thereof.
The present disclosure relates to novel crystalline forms... |
|
Invention
|
Anti-tumor agent containing taxane compound, and anti-tumor effect enhancer.
In order to provide... |
|
Invention
|
Combination decitabine and cedazuridine solid oral dosage forms.
Embodiments of the present inve... |
|
Invention
|
Chemotherapy for cancer using azabicyclo compound.
Provided are a novel cancer treatment method ... |
|
Invention
|
Method of treating malignant tumor by azabicyclic compound.
Provided is a method of treating mal... |
|
Invention
|
Combination therapy using azabicyclo compound for cancer.
Provided is a novel method for treatin... |
|
G/S
|
Anti-cancer preparations; pharmaceutical preparations for the treatment of tumor; chemical reagen... |
|
Invention
|
L718 and/or l792 mutant treatment-resistant egfr inhibitor.
The present invention provides an an... |
|
Invention
|
2'-deoxy-2',2'-difluorotetrahydrouridines with high purity and methods of making the same.
The i... |
2024
|
Invention
|
Brain-migrating tumor treatment agent containing, as active ingredient, n-(4-(4-amino-6-ethynyl-5... |
|
G/S
|
Pharmaceutical preparations for use in dermatology, wounds, treating diabetes, analgesics, eye-wa... |
|
Invention
|
Crystals of 7h-pyrrolo[2,3-d]pyrimidin-4-amine derivatives. Crystalline forms of N-(4-(4-amino-6-... |
|
Invention
|
Methods of treating cancer using futibatinib, pembrolizumab and at least one additional chemother... |
|
Invention
|
Cancer therapy including 3,5-disubstituted benzene alkynyl compound and immune checkpoint inhibit... |
|
Invention
|
Cancer combination therapy using aza bicyclic compound and antiandrogen agent. Provided is a nove... |
|
Invention
|
Treatment methods for subjects with non-small cell lung cancer having an aberration in egfr. A me... |
|
Invention
|
Crystal of quinoline-substituted compound. The present invention addresses the problem of providi... |
|
Invention
|
Pharmaceutical composition. The purpose of the present invention is to provide a pharmaceutical c... |
|
Invention
|
Prophylactic drug/therapeutic drug for progressive supranuclear palsy. Provided is a novel prophy... |
|
Invention
|
Antibody-drug conjugate containing anti-cd138 antibody. Provided is an antibody-drug conjugate (A... |
|
Invention
|
Ftd-tpi combination preparation, pd-1 pathway antagonist, and combination use of vegf pathway ant... |
|
Invention
|
Method for treating cancer patients with severe renal impairment.
A method for treating cancer i... |
2023
|
Invention
|
Crystals of acetate hydrochloride. The present invention provides I form crystals of 4-piperidiny... |
|
Invention
|
Selective inhibitor of exon 20 insertion mutant egfr.
An antitumor agent comprising a compound s... |
|
Invention
|
Methods of treating cancer using futibatinib and pembrolizumab. The present disclosure relates to... |
|
Invention
|
Cancer therapy using 3,5-disubstituted benzene alkynyl compound and immune checkpoint inhibitor. ... |
|
Invention
|
5h-pyrrolo[2,3-d]pyrimidin-6(7h)-one and crystal of salt thereof. Provided is a type-I crystal of... |
|
Invention
|
Pharmaceutical composition containing pimitespib. Provided is a pharmaceutical composition contai... |
|
Invention
|
Analogues of azabicyclic compounds. Provided are novel compounds which are analogues to be remove... |
|
G/S
|
Advertising and publicity services; business management analysis and business consultancy; busine... |
|
Invention
|
Method for producing 7h-pyrrolo[2,3-d]pyrimidine-4-amine derivative. The present invention provid... |
|
Invention
|
Ph-dependent anti-sulfated glycosaminoglycan antibody and antibody-drug conjugate. This invention... |
|
Invention
|
Ph-dependent anti-sulfated glycosaminoglycan antibody and antibody-drug conjugate.
This inventio... |
|
Invention
|
Crystal form of cyclohexenone compound.
An object of the present disclosure is to provide a crys... |
|
Invention
|
Crystal form of cyclohexenone compound. An object of the present disclosure is to provide a cryst... |
2022
|
Invention
|
Combination therapies for treatment of t-cell lymphomas with tolinapant, cedazuridine and decitabine |
|
Invention
|
Process for preparing a benzoate salt of a 1-(3-aminopyrrolidine-1-carbonyl)-3,4-diphenylbenzene ... |
|
Invention
|
Treatment methods for subjects having cancer with a dysregulated mapk and/or pi3k pathway.
A met... |
|
Invention
|
Anti-growth hormone antibody.
In one embodiment, the present invention provides an antibody spec... |
|
Invention
|
New juniper pollen protein.
The present disclosure relates to a juniper pollen protein selected ... |
|
Invention
|
Small molecule inhibitors of kras mutated proteins.
Compounds of Formula (I) or their pharmaceut... |
|
Invention
|
Treatment methods for subjects with cancer having an aberration in egfr and/or her2.
A method of... |
|
Invention
|
Solid forms of salts of 4-[5-[(3s)-3-aminopyrrolidine-1-carbonyl]-2-[2-fluoro-4-(2- hydroxy-2-eth... |
|
Invention
|
Treating cancer in patient with pten inactivating mutation.
A method of treating a subject with ... |
2021
|
Invention
|
Brain-migrating tumor therapeutic agent containing fused pyrimidine compound as active ingredient... |
|
Invention
|
Crystalline forms of 4-amino-n-[4-(methoxymethyl)phenyl]-7-(1-methylcyclopropyl)-6-(3-morpholinop... |
|
Invention
|
Methods of using 4-amino-n-[4-(methoxymethyl)phenyl]-7-(1-methylcyclopropyl)-6-(3-morpholinoprop-... |
|
Invention
|
Methods of treating ribonucleotide reductase-related diseases with a ribonucleotide reductase inh... |
|
Invention
|
Treating cancer in patient having co-occurring genetic alteration in fgfr2 and a cancer driver ge... |
|
G/S
|
Application software; computer programs; electronic
machines, apparatus and their parts; smartph... |
|
G/S
|
Downloadable application software for processing images, graphics and text; downloadable computer... |
|
G/S
|
Pharmaceutical, veterinary and sanitary preparations; dietary supplements for medical purposes; D... |
|
G/S
|
Anti-cancer preparations; pharmaceutical preparations for the treatment of tumors; chemical reage... |
2020
|
Invention
|
Polypeptide having mmp2-inhibitory effect.
The present invention provides a substituted polypept... |